Application and investment of AI in the pharmaceutical industry is rapidly gaining momentum. We bring together CEOs, CIOs, CTOs and Global AI, IT and Informatics Experts from leading pharmaceutical and technology companies to give strategic talks from a business perspective together with use cases from across the drug development pipeline.

Thursday, October 24 - Friday, October 25

Business Value Outcomes

Opening Remarks 
Alan Louie, PhD, Research Director, Life Sciences, IDC

KEYNOTE: What Does the World's First Biotech Born in AI Do Differently and Why? 
Milind Kamkolkar, Chief Data Officer, Cellarity; Former Chief Data Officer, Sanofi 

How to Integrate AI into the Pharmaceutical Business Model

Dorothee B. Bartels, PhD, Chief Digital Science Officer, BI X (Boehringer Ingelheim’s Digital Lab)

Linking Artificial Intelligence to Business Outcomes
Angeli Möller, PhD, Head of IT Business Partnering Research, Pharmaceuticals Division, Bayer

CO-PRESENTATION: Bridging Business and Technical Functions: How to Translate AI Between the Two
Natalija Jovanovic, PhD, Head Digital Catalyst, Sanofi
Eduardo Cornejo, ITS Digital Innovation Market Lead, Sanofi

PANEL: Assessing the Impact of AI on Business Strategies in the Pharmaceutical Industry
Panelists: Abel Archundia, Global Head of IT, Bayer Pharmaceuticals
Dorothee B. Bartels, PhD, Chief Digital Science Officer, BI X (Boehringer Ingelheim’s Digital Lab)
Sebastien Lefebvre, Senior Director, Data Sciences, Genomics and Bioinformatics, Alexion Pharmaceuticals

Cross Functional Impact of AI

Opening Remarks 
Mike Townsend, Research Manager, Life Sciences Commercial Strategies, IDC


The Nature of an AI Revolution and What it Means for Pharma

Peter Henstock, PhD, AI & Machine Learning Lead, Pfizer

Transforming Portfolio Decision Making Through the Use of AI
Ivan Kugener, MD, VP, Head of Global Portfolio Management, Valuation & Analytics, Merck

DISRUPTING Drug Discovery

PANEL: Revolutionizing Drug Discovery with Artificial Intelligence and Machine Learning  
Panelists: Ron Alfa, MD, PhD, Senior Vice President, Translational Discovery, Recursion Pharmaceuticals
Timothy Lu, PhD, MD, Co-Founder and CEO, Senti Biosciences
Shantanu Singh, PhD, Senior Group Leader, Imaging Platform, Broad Institute of Harvard and MIT